Gerald Gartlehner

Summary

Affiliation: Danube University Krems
Country: Austria

Publications

  1. ncbi The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    Drug Saf 32:1159-73. 2009
  2. ncbi [Balancing benefits and harms of population-based interventions, using the example of cancer screening]
    Gerald Gartlehner
    Department für Evidenzbasierte Medizin und Klinische Epidemiologie, Donau Universität Krems Österreich
    Z Evid Fortbild Qual Gesundhwes 105:176-82. 2011
  3. ncbi Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis
    Gerald Gartlehner
    Danube University, Krems, Austria
    Ann Intern Med 155:772-85. 2011
  4. ncbi Direct versus indirect comparisons: a summary of the evidence
    Gerald Gartlehner
    Danube University, Krems, Austria
    Int J Technol Assess Health Care 24:170-7. 2008
  5. ncbi The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: secondary analysis of a systematic review
    Gerald Gartlehner
    Department of Evidence Based Medicine and Clinical Epidemiology, Danube University, Krems, Austria
    J Clin Epidemiol 63:117-25. 2010
  6. ncbi Inadequate reporting of trials compromises the applicability of systematic reviews
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University, Krems, Austria
    Int J Technol Assess Health Care 25:323-30. 2009
  7. ncbi Assessment of adverse effects and applicability--two areas not (yet) covered adequately in Cochrane reports
    Gerald Gartlehner
    Danube University, Krems, Austria
    Z Evid Fortbild Qual Gesundhwes 102:497-502. 2008
  8. ncbi Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians
    Gerald Gartlehner
    Danube University, Krems, Austria
    Ann Intern Med 149:734-50. 2008
  9. ncbi Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    Drug Saf 31:851-65. 2008
  10. ncbi Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    PLoS ONE 5:e11895. 2010

Detail Information

Publications16

  1. ncbi The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    Drug Saf 32:1159-73. 2009
    ..Second-generation antidepressants dominate the management of patients with major depressive disorder (MDD). Evidence on the general and comparative benefits and harms is still accruing...
  2. ncbi [Balancing benefits and harms of population-based interventions, using the example of cancer screening]
    Gerald Gartlehner
    Department für Evidenzbasierte Medizin und Klinische Epidemiologie, Donau Universität Krems Österreich
    Z Evid Fortbild Qual Gesundhwes 105:176-82. 2011
    ..Studies, however, indicate that the prerequisite for informed decision making, namely objective and balanced information about benefits and harms, is often missing...
  3. ncbi Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis
    Gerald Gartlehner
    Danube University, Krems, Austria
    Ann Intern Med 155:772-85. 2011
    ..Second-generation antidepressants dominate the management of major depressive disorder (MDD), but evidence on the comparative benefits and harms of these agents is contradictory...
  4. ncbi Direct versus indirect comparisons: a summary of the evidence
    Gerald Gartlehner
    Danube University, Krems, Austria
    Int J Technol Assess Health Care 24:170-7. 2008
    ..The aim of this study was to provide a comprehensive summary and interpretation of the current evidence on the use and validity of statistical methods to conduct indirect comparisons of treatment effects...
  5. ncbi The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: secondary analysis of a systematic review
    Gerald Gartlehner
    Department of Evidence Based Medicine and Clinical Epidemiology, Danube University, Krems, Austria
    J Clin Epidemiol 63:117-25. 2010
    ..The objective of this study was to determine the effect of industry bias in a systematically reviewed body of evidence of head-to-head trials...
  6. ncbi Inadequate reporting of trials compromises the applicability of systematic reviews
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University, Krems, Austria
    Int J Technol Assess Health Care 25:323-30. 2009
    ..This study aimed to determine whether information reported in studies included in systematic reviews was adequate enough to assess their applicability...
  7. ncbi Assessment of adverse effects and applicability--two areas not (yet) covered adequately in Cochrane reports
    Gerald Gartlehner
    Danube University, Krems, Austria
    Z Evid Fortbild Qual Gesundhwes 102:497-502. 2008
    ....
  8. ncbi Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians
    Gerald Gartlehner
    Danube University, Krems, Austria
    Ann Intern Med 149:734-50. 2008
    ..Second-generation antidepressants dominate the management of major depressive disorder, dysthymia, and subsyndromal depression. Evidence on the comparative benefits and harms is still accruing...
  9. ncbi Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    Drug Saf 31:851-65. 2008
    ..However, a comprehensive assessment of both benefits and harms is crucial to evaluate the net benefit...
  10. ncbi Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review
    Gerald Gartlehner
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    PLoS ONE 5:e11895. 2010
    ..The available body of evidence, however, was limited in quality and quantity, confining the range and certainty of our conclusions...
  11. ncbi Second-generation antidepressants for seasonal affective disorder
    Kylie Thaler
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    Cochrane Database Syst Rev 12:CD008591. 2011
    ..Seasonal affective disorder (SAD) is a seasonal pattern of recurrent depressive episodes that is often treated with second-generation antidepressants (SGAs), light therapy or psychotherapy...
  12. ncbi [Austrian patient information materials on PSA-screening do not meet international evidence-based standards]
    Michaela Strobelberger
    Department für Evidenzbasierte Medizin und Klinische Epidemiologie, Donau Universität, Krems, Austria
    Wien Med Wochenschr 161:89-98. 2011
    ..The aim of this paper was to evaluate all in Austria available patient information materials on PSA-screening with regard to their evidence-based content and their potential to facilitate informed decision-making...
  13. ncbi Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents
    Angela Kaminski
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Dr Karl Dorrek Strasse 30, Krems, Austria, 3500
    Cochrane Database Syst Rev 7:CD008013. 2011
    ..To date, the evidence on the benefits and harms of antidepressants for the treatment of abdominal pain-related FGIDs has not been assessed systematically...
  14. ncbi Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project
    Kylie Thaler
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    Biologics 3:485-98. 2009
    ..To systematically review the general and comparative efficacy and safety of anakinra for rheumatoid arthritis...
  15. ncbi Bach Flower Remedies for psychological problems and pain: a systematic review
    Kylie Thaler
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University, Krems, A 3500, Austria
    BMC Complement Altern Med 9:16. 2009
    ..We assessed whether Bach Flower Remedies (BFRs) are safe and efficacious for these indications by performing a systematic review of the literature...
  16. ncbi Semi-automating the manual literature search for systematic reviews increases efficiency
    Andrea L Chapman
    Department for Evidence based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria
    Health Info Libr J 27:22-7. 2010
    ....